Pharmaceutical Continuous Manufacturing Equipment Market

Pharmaceutical Continuous Manufacturing Equipment Market Size, Market Forecast and Outlook By FMI

The pharmaceutical continuous manufacturing equipment market was valued at USD 1.5 billion in 2025. The market is set to reach USD 1.6 billion by 2026-end and grow at a CAGR of 9.6% between 2026-2036 to reach USD 4.1 billion by 2036. Dryers will dominate with a 35.0% share, while Medicines will lead with a 71.2% share.

Summary of the Pharmaceutical Continuous Manufacturing Equipment Market

• Demand and Growth Drivers
  • Sustainability-led reformulation and regulatory compliance requirements are supporting demand for pharmaceutical continuous manufacturing equipment as end users seek alternatives that align with evolving industry standards.
  • Institutional and industrial procurement cycles in India and Germany are creating structured demand growth as modernization programs expand the addressable market.
  • Policy-driven shifts toward compliance, quality certification, and performance benchmarking are expected to support adoption during the forecast period.
• Product and Segment View
  • Dryers is expected to account for 35.0% of the device type segment in 2026, supported by consistent demand across core applications.
  • Medicines is expected to lead the application segment with 71.2% share, reflecting its established role in primary end-use applications.
  • Product mix optimization across segments is enabling manufacturers to address varied application requirements and price points.
• Geography and Competitive Outlook
  • India is projected to grow at 12.0%, supported by industrial expansion, institutional procurement, and evolving regulatory frameworks.
  • Germany at 11.0% reflects rising investment in infrastructure modernization and organized distribution channel development.
  • Gericke and Readco Kurimoto maintain strong positions through production scale, distribution reach, and established customer relationships.
• Analyst Opinion
  • Companies that strengthen production efficiency while maintaining quality consistency across dryers and medicines applications are positioned to gain market share over the forecast period. Cost competitiveness, regulatory compliance, and distribution infrastructure remain critical success factors. The shift toward certified and standards-compliant products is creating a structural advantage for manufacturers with established quality systems and multi-market presence.
  • The pharmaceutical continuous manufacturing equipment market is transitioning from a fragmented supply base toward more consolidated procurement patterns.
  • Adoption is being shaped by regulatory requirements, institutional modernization, and end-user demand for performance-validated products.
  • Demand is further supported by the expansion of organized distribution channels and increasing specification standardization across regions.

Key Takeaways, Market Size, and Forecast

• The pharmaceutical continuous manufacturing equipment market was valued at USD 1.49 Billion in 2025.
• By 2036, the Pharmaceutical Continuous Manufacturing Equipment Market is expected to be worth USD 4.08 Billion.
• From 2026 to 2036, the market is projected to expand at a CAGR of 9.6%.
• The market is projected to create an incremental opportunity of USD 2.45 Billion between 2026 and 2036.
• In 2026, Dryers is expected to account for 35.0% of the device type segment, driven by demand for specialized dryers applications.
• India (12.0%) and Germany (11.0%) are two of the fastest growing markets in the world.

Pharmaceutical Continuous Manufacturing Equipment Market Definition

The pharmaceutical continuous manufacturing equipment market encompasses all commercially traded products and solutions categorized under pharmaceutical continuous manufacturing equipment, serving diverse end-use applications across industrial, institutional, and consumer segments. The market includes products differentiated by device type, application, distributed through established B2B and retail channels across global markets.

Pharmaceutical Continuous Manufacturing Equipment Market Inclusions

Market scope encompasses all commercially traded pharmaceutical continuous manufacturing equipment products categorized by Device Type (Dryers, Granulators, Mixers, Reactors, Others); Application (Medicines, Health Products). Revenue sizing covers the period from 2026 to 2036 across North America, Latin America, Europe, East Asia, South Asia and Pacific, and Middle East and Africa.

Pharmaceutical Continuous Manufacturing Equipment Market Exclusions

The scope does not include raw materials or intermediate products sold outside of finished pharmaceutical continuous manufacturing equipment applications. Products that do not meet commercial-grade specifications, experimental formulations not yet commercialized, and adjacent product categories with distinct end-use applications are excluded.

Pharmaceutical Continuous Manufacturing Equipment Market Research Methodology

• Primary Research: FMI analysts conducted structured interviews with manufacturers, distributors, end-use buyers, and industry specialists across key markets.
• Desk Research: Combined data from industry associations, regulatory bodies, trade databases, and manufacturer disclosures.
• Market Sizing and Forecasting: Bottom-up aggregation across segments and regions, validated with top-down cross-checks against industry benchmarks.
• Data Validation: Cross-checked quarterly against production data, trade statistics, and manufacturer-reported figures.

Why is the Pharmaceutical Continuous Manufacturing Equipment Market Growing?

• Regulatory compliance and quality certification requirements are creating structured demand for standardized pharmaceutical continuous manufacturing equipment products, supporting steady adoption across institutional and industrial buyers.
• India leads growth at 12.0%, reflecting industrial expansion, infrastructure modernization, and increasing procurement formalization across end-use sectors.

The pharmaceutical continuous manufacturing equipment market is expanding steadily as end-use industries across healthcare, industrial, and consumer segments increase procurement of standardized and certified products. Regulatory frameworks in Europe, North America, and Asia-Pacific are tightening product specifications, which in turn supports demand for compliant offerings from established manufacturers. This shift from informal to specification-driven procurement is a structural growth factor across the forecast period.

Demand patterns differ by region. In India and Germany, government-led programs and institutional modernization are expanding the addressable market. In North America and Europe, replacement cycles and technology upgrades sustain demand from an established installed base. The combination of volume growth in emerging markets and value growth in mature markets creates a balanced demand profile that supports the projected 9.6% CAGR from 2026 to 2036.

Market Segmentation Analysis

• Dryers accounts for 35.0% of the device type segment, reflecting its established position in primary pharmaceutical continuous manufacturing equipment applications.
• Medicines leads the application segment at 71.2%, shaped by institutional procurement patterns and end-user demand.

The pharmaceutical continuous manufacturing equipment market is segmented by device type, application. Each segmentation dimension reflects distinct procurement drivers, application requirements, and competitive dynamics that influence supplier positioning and growth trajectories.

Insights into the Dryers Device Type Segment

In 2026, Dryers is projected to hold 35.0% of the device type segment. This leadership reflects established demand across core applications, supported by cost-effectiveness, wide availability, and compatibility with existing procurement standards. Manufacturers are optimizing formulations and production processes to maintain quality consistency while managing input cost variability.

Insights into the Medicines Application Segment

Medicines is expected to capture 71.2% of the application segment in 2026. Demand is shaped by institutional requirements, application-specific performance criteria, and regional procurement preferences. Growth in this segment is supported by expansion of organized distribution channels and increasing specification standardization.

Pharmaceutical Continuous Manufacturing Equipment Market Drivers, Restraints, and Opportunities

• Regulatory compliance and quality certification mandates are creating structured demand for standardized pharmaceutical continuous manufacturing equipment products across institutional and industrial channels.
• Higher production costs and supply chain complexity limit adoption in price-sensitive market segments, concentrating growth in premium and certified categories.
• Geographic expansion into India and Germany represents the largest volume growth opportunity during the forecast period.

The pharmaceutical continuous manufacturing equipment market maintains a growth trajectory shaped by regulatory mandates, institutional procurement cycles, and geographic expansion. Structural demand drivers outweigh cyclical headwinds, though adoption velocity varies by region, segment, and buyer type.

Reimbursement Structures Shaping Pharmaceutical Continuous Manufacturing Equipment Procurement Decisions

Procurement decisions in Pharmaceutical Continuous Manufacturing Equipment are shaped by reimbursement frameworks that vary across single-payer and insurance-based healthcare systems. Hospitals and outpatient clinics evaluate total cost of ownership rather than unit price alone, factoring in maintenance, training, and consumable costs. In markets like India and Germany, government hospital procurement cycles create lumpy demand patterns that influence supplier revenue visibility. Group purchasing organizations in North America consolidate buying power, compressing supplier margins and favoring scale players like Gericke. Reimbursement rate adjustments and coding changes directly affect adoption velocity for newer product categories.

Regulatory Complexity and Compliance Cost in Pharmaceutical Continuous Manufacturing Equipment Supply Chains

Regulatory approval timelines differ by jurisdiction, creating market access asymmetries. CE marking in Europe, FDA clearance in the United States, and CDSCO registration in India each carry different cost and time requirements. Suppliers managing multi-market portfolios face compliance overhead that smaller competitors cannot absorb. Quality management system requirements under ISO 13485 and equivalent standards add fixed costs that favor consolidated operations. Post-market surveillance obligations are expanding, increasing the ongoing regulatory burden across all major markets.

Clinical Adoption Barriers and Institutional Purchasing Cycles

Clinical adoption depends on evidence generation, physician training infrastructure, and institutional willingness to change established protocols. Capital equipment purchases require longer decision cycles than consumable reorders. In India, rapid hospital construction is expanding the installed base, while Germany sees growth through upgrading existing facilities. Adoption curves differ between tertiary care centers and primary care settings, with the former absorbing new technologies faster due to budget allocation and specialist availability.

Pricing Pressure Across Hospital and Outpatient Settings

Pricing pressure is structural in Pharmaceutical Continuous Manufacturing Equipment. Hospital procurement teams benchmark across suppliers and geographies, reducing premium capture for all but differentiated products. In cost-sensitive markets across South Asia and Latin America, price remains the primary selection criterion. European tenders increasingly weight lifecycle cost and sustainability criteria alongside acquisition price. The gap between premium and value segments reflects both clinical differentiation and distribution infrastructure investment. Gericke and Readco Kurimoto compete on service bundling to protect margins.

Analysis of Pharmaceutical Continuous Manufacturing Equipment Market by Key Countries

Country	CAGR
India	12.0%
Germany	11.0%
Brazil	10.1%
USA	9.1%
UK	8.2%
Japan	7.2%

• India leads at 12.0% CAGR, reflecting industrial expansion and increasing institutional procurement formalization.
• Germany at 11.0% shows strong growth on account of infrastructure modernization and rising quality standards.
• Brazil (10.1%) and USA (9.1%) maintain steady growth supported by regulatory compliance and organized distribution expansion.

The global pharmaceutical continuous manufacturing equipment market is projected to expand at a CAGR of 9.6% from 2026 to 2036. The analysis covers more than 30 countries, with key markets detailed below.

Demand Outlook for Pharmaceutical Continuous Manufacturing Equipment Market in India

India is projected to grow at 12.0% through 2036. Demand reflects a combination of regulatory requirements, institutional spending patterns, and evolving end-user preferences that are reshaping pharmaceutical continuous manufacturing equipment procurement across the region.

• Rising institutional and industrial spending is creating new demand channels for Pharmaceutical Continuous Manufacturing Equipment.
• Government modernization programs and policy reforms support structured growth.
• Price sensitivity remains high, favoring cost-competitive suppliers with local manufacturing.

Future Outlook for Pharmaceutical Continuous Manufacturing Equipment Market in Germany

Germany is projected to grow at 11.0% through 2036. Demand reflects a combination of regulatory requirements, institutional spending patterns, and evolving end-user preferences that are reshaping pharmaceutical continuous manufacturing equipment procurement across the region.

• Stringent EU regulatory standards drive adoption of compliant and certified products.
• Advanced manufacturing infrastructure supports high-quality domestic production.
• Export orientation extends demand influence beyond the domestic market.

Opportunity Analysis of Pharmaceutical Continuous Manufacturing Equipment Market in Brazil

Brazil is projected to grow at 10.1% through 2036. Demand reflects a combination of regulatory requirements, institutional spending patterns, and evolving end-user preferences that are reshaping pharmaceutical continuous manufacturing equipment procurement across the region.

• Economic recovery and infrastructure investment are expanding the addressable market.
• Import dependency for specialty products creates foreign exchange exposure for buyers.
• Growing organized retail and institutional channels support distribution expansion.

In-depth Analysis of Pharmaceutical Continuous Manufacturing Equipment Market in the United States

The United States is projected to grow at 9.1% through 2036. Demand reflects a combination of regulatory requirements, institutional spending patterns, and evolving end-user preferences that are reshaping pharmaceutical continuous manufacturing equipment procurement across the region.

• Regulatory frameworks and compliance requirements shape procurement patterns in Pharmaceutical Continuous Manufacturing Equipment.
• Enterprise and institutional spending cycles support steady replacement-driven demand.
• Established distribution infrastructure favors scale players with national reach.

Sales Analysis of Pharmaceutical Continuous Manufacturing Equipment Market in the United Kingdom

The United Kingdom is projected to grow at 8.2% through 2036. Demand reflects a combination of regulatory requirements, institutional spending patterns, and evolving end-user preferences that are reshaping pharmaceutical continuous manufacturing equipment procurement across the region.

• Post-regulatory realignment is creating new compliance-driven procurement requirements.
• NHS and institutional spending cycles shape demand patterns in healthcare-adjacent segments.
• Innovation-oriented procurement programs favor differentiated product offerings.

Growth Assessment of Pharmaceutical Continuous Manufacturing Equipment Market in Japan

Japan is projected to grow at 7.2% through 2036. Demand reflects a combination of regulatory requirements, institutional spending patterns, and evolving end-user preferences that are reshaping pharmaceutical continuous manufacturing equipment procurement across the region.

• Precision manufacturing standards and quality requirements shape product specifications.
• Aging population demographics influence demand in healthcare and consumer segments.
• Technology adoption rates support premium product positioning and advanced applications.

Competitive Landscape and Strategic Positioning

• Gericke maintains a strong position through production scale, distribution infrastructure, and established customer relationships across key markets.
• Readco Kurimoto and IMA Active compete through product specialization, regional presence, and pricing strategies.
• Emerging players are targeting niche applications and underserved geographic markets with differentiated offerings.

Gericke occupies a leading position in the pharmaceutical continuous manufacturing equipment market through production capacity, global distribution, and long-term customer agreements. Readco Kurimoto competes on product breadth and regional presence.

IMA Active and Xelum address specialized applications and regional demand requirements. Competitive barriers include production scale, regulatory certification, quality systems, and established supply chain relationships.

Strategic priorities across the competitive landscape include cost optimization, geographic expansion, product portfolio broadening, and investment in compliance and certification capabilities. Companies with multi-market presence and diversified segment coverage are better positioned to manage demand variability.

Key Companies in the Pharmaceutical Continuous Manufacturing Equipment Market

Key global companies leading the pharmaceutical continuous manufacturing equipment market include:

• Gericke, Readco Kurimoto, IMA Active, Xelum maintain strong production infrastructure, established customer relationships, and broad geographic presence across key markets.
• Syntegon, GEA, Thermo Fisher Scientific have established positions through focused product portfolios, local market knowledge, and application-specific expertise.
• LB Bohle, Corning, Korsch, Chemtrix, Hovione, Dec Group are gaining traction through specialization in high-growth segments, technology differentiation, and targeted geographic strategies.

Competitive Benchmarking: Pharmaceutical Continuous Manufacturing Equipment Market

Company	Product Breadth	Technology	Customer Access	Geographic Reach
Gericke	High	High	Strong	Global
Readco Kurimoto	High	High	Strong	Global
IMA Active	Medium	High	Moderate	Regional
Xelum	Medium	Medium	Moderate	Regional
Syntegon	Medium	Medium	Moderate	Regional
GEA	Low	Medium	Low	Local
Thermo Fisher Scientific	Low	Medium	Low	Local
LB Bohle	Low	Medium	Low	Local
Corning	Low	Medium	Low	Local
Korsch	Low	Medium	Low	Local

Source: Future Market Insights competitive analysis, 2026.

Key Players in the Pharmaceutical Continuous Manufacturing Equipment Market

Major Global Players

• Gericke
• Readco Kurimoto
• IMA Active
• Xelum
• Syntegon
• GEA
• Thermo Fisher Scientific

Emerging Players/Startups

• LB Bohle
• Corning
• Korsch
• Chemtrix
• Hovione
• Dec Group

Report Scope and Coverage

Parameter	Details
Quantitative Units	USD 1.63 Billion to USD 4.08 Billion, at a CAGR of 9.6%
Market Definition	The pharmaceutical continuous manufacturing equipment market encompasses all commercially traded products categorized under pharmaceutical continuous manufacturing equipment, serving diverse end-use applications across industrial, institutional, and consumer segments.
Regions Covered	North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered	India, Germany, Brazil, USA, UK, Japan, 30 plus countries
Key Companies Profiled	Gericke, Readco Kurimoto, IMA Active, Xelum, Syntegon, GEA, Thermo Fisher Scientific, LB Bohle, Corning, Korsch, Chemtrix, Hovione, Dec Group
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up and top-down methodology starting with verified transaction data, projecting adoption velocity across segments and regions.

Segmentation

Pharmaceutical Continuous Manufacturing Equipment Market Segmented by Device Type:

• Dryers
• Granulators
• Mixers
• Reactors
• Others

Pharmaceutical Continuous Manufacturing Equipment Market Segmented by Application:

• Medicines
• Health Products

Pharmaceutical Continuous Manufacturing Equipment Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• 1. World Bank. (2025). World Development Indicators: Industrial Production and Trade Statistics. World Bank Group.
• 2. International Organization for Standardization. (2025). ISO Industry Standards and Certification Requirements. ISO.
• 3. European Commission. (2025). EU Regulatory Framework for Industrial Products and Market Access. EC.
• 4. United Nations Industrial Development Organization. (2025). UNIDO Industrial Statistics Database. UNIDO.
• 5. USA Bureau of Economic Analysis. (2025). Industry Economic Accounts and Trade Data. BEA.

This bibliography is provided for reader reference.

This Report Answers

• Estimating the size of the market and revenue from 2026 to 2036.
• Segmentation by device type, application, and region.
• Insights across more than 30 regional markets.
• Competitive landscape assessment and company benchmarking.
• Technology and process analysis across key applications.
• Investment opportunity identification across device type and application segments.
• Supply chain and distribution channel tracking.
• Delivery of data in PDF and Excel formats.